NeuroBell develops compact, wireless EEG monitoring systems designed to detect seizures in newborns at the bedside. The company’s platform is pocket-sized and optimized for use in neonatal intensive care units, where rapid detection of abnormal brain activity is critical. Its approach focuses on enabling continuous neurological monitoring without the complexity of traditional EEG setups. NeuroBell positions its technology within regulated clinical care environments.

The technology records EEG signals using a simplified, wireless configuration suitable for neonatal use. AI-driven algorithms analyze the data in real time to identify patterns consistent with seizure activity. By automating detection, the system aims to reduce reliance on specialist interpretation and minimize delays in diagnosis. The design emphasizes ease of use, rapid deployment, and integration into routine NICU workflows.

NeuroBell targets neonatal seizure detection and monitoring, supporting early intervention during a critical period of brain development. The platform is intended for use by clinical teams in hospital settings rather than for consumer or home monitoring. Its focus reflects broader efforts to improve access to timely neurological assessment in neonatal care through portable, AI-enabled tools.